Clinical trial · Interventional
Study About no Antimicrobial Prophylaxis in Totally Laparoscopic Distal Gastrectomy
Multicenter Randomized Controlled Trial About no Antimicrobial Prophylaxis for Patients Undergoing Totally Laparoscopic Distal Gastrectomy for Gastric Carcinoma (KSWEET-03)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Laparoscopic gastrectomy has fewer infectious complications compared to open surgery. Recently, the incidence of postoperative infectious complications was greatly reduced due to the development of surgical techniques and improvement of prevention and control of surgical infection. Previous multicenter, phase II study (KSWEET-01) revealed that the incidence of infectious complications of laparoscopic gastrectomy without prophylactic antibiotics was not significantly higher than previously reported data. Therefore, this study aim to prove the safety of totally laparoscopic distal gastrectomy without prophylactic antibiotics, specially reference to the postoperative infectious complications.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Complication of Surgical Procedure | — | UNRESOLVED | — |
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No use of antimicrobial prophylaxis | Procedure | — | UNRESOLVED |
| Use of antimicrobial prophylaxis | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- A group (treatment group)
- description
- No use of antimicrobial prophylaxis
- interventionNames
- Procedure: No use of antimicrobial prophylaxis
- type
- EXPERIMENTAL
- label
- B group (control group)
- description
- Use of antimicrobial prophylaxis
- interventionNames
- Procedure: Use of antimicrobial prophylaxis
Primary outcomes (1)
- measure
- Incidence of surgical site infections within 30 days
- timeFrame
- within 30 days after operation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * A patient undergoing totally laparoscopic distal gastrectomy for the gastric cancer located in the low or middle part of the stomach * A patient who underwent limited lymphadenectomy (D1 or D1+) with clinical T1-2N0M0 stage based on 8th edition of the International Union Against Cancer (UICC) tumor node metastasis (TNM) classification * From 18 to 75 years old * Eastern Cooperative Oncology Group (ECOG) status 0-1 * American Society of Anesthesiologists (ASA) score I-II * A patient with appropriate bone marrow function, renal function, lung function, and liver function * Before the surgery, decide to participate in this study and agree with the written informed consent Exclusion Criteria: * A patient who underwent previous abdominal surgery * Combined other abdominal organ cancer * A patient who received chemotherapy and radiotherapy within the last 6 months * Combined organ resection other than cholecystectomy * A patient undergoing emergency surgery due to perforation or bleeding * A patient who have received antibiotic treatment for other infectious diseases within one month of operation * Severely malnourished patient
References
Publications (0)
Data not yet available